Mas receptor is involved in the estrogen-receptor induced nitric oxide-dependent vasorelaxation


Por: Sobrino A, Vallejo S, Novella S, Lazaro-Franco M, Mompeon A, Bueno-Beti C, Walther T, Sanchez-Ferrer C, Peiro C, Hermenegildo C

Publicada: 1 abr 2017
Resumen:


Filiaciones:
Sobrino A:
 INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia, and Department of Physiology, University of Valencia, Spain

Vallejo S:
 Department of Pharmacology, University Autonoma of Madrid, Spain

Novella S:
 INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia, and Department of Physiology, University of Valencia, Spain

Lazaro-Franco M:
 INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia, and Department of Physiology, University of Valencia, Spain

Mompeon A:
 INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia, and Department of Physiology, University of Valencia, Spain

Bueno-Beti C:
 INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia, and Department of Physiology, University of Valencia, Spain

Walther T:
 Department of Pharmacology and Therapeutics, School of Medicine School of Pharmacy, University College Cork, Cork, Ireland

Sanchez-Ferrer C:
 Department of Pharmacology, University Autonoma of Madrid, Spain

Peiro C:
 Department of Pharmacology, University Autonoma of Madrid, Spain

Hermenegildo C:
 INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia, and Department of Physiology, University of Valencia, Spain
ISSN: 00062952





BIOCHEMICAL PHARMACOLOGY
Editorial
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 129 Número:
Páginas: 67-72
WOS Id: 000396965800006
ID de PubMed: 28131844

MÉTRICAS